For a politics nut, Denmark has another point of interest. It is one of the hardest countries to place philosophically. It ...

Brazilian drugmaker Hypera plans to launch next year a generic version of semaglutide, the active ingredient of Novo Nordisk's blockbuster diabetes and weight-loss drug Ozempic, Hypera's chief ...

Novo Nordisk’s Wegovy is about to enter the Irish market but people will have to pay for it from their own pocket - for now ...

Earlier this year, when US President Donald Trump offered to buy Greenland from Denmark, online rumours circulated that the Danish government might encourage Novo Nordisk, the Danish company behind ...

Eli Lilly launches anti-obesity and diabetes drug Mounjaro in India, priced competitively at Rs 14,000-17,500, a fraction of ...

As evident, Hazlitt’s one lesson has vast applications. This essay now delves into its deployment on the Danish welfare state ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Pharmaceutical companies are currently granted at least eight years’ “protection” over their data from research and clinical ...

He and his team then compared the diagnoses for hair loss in these patients’ medical records and found that those prescribed ...

The second cycle of negotiations will take place under President Donald Trump's administration. The U.S. government has said ...

Scientists have identified the Plvap gene as a key regulator of metabolism during fasting. Disabling it in mice prevented the ...

Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss ...